wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agents, pharmaceutical formulations, and methods for the preparation of the compounds.
摘要:
Disclosed are compounds of the formula wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agents, pharmaceutical formulations, and methods for the preparation of the compounds.
wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agents, pharmaceutical formulations, and methods for the preparation of the compounds.
摘要翻译:公开了下式的化合物:其中R 1是氢; R 2是嘌呤或嘧啶碱或其类似物或衍生物; Z是S,S = O或SO 2; 及其药学可接受的衍生物。 还描述了这些化合物作为抗病毒剂,药物制剂和制备该化合物的方法的用途。
摘要:
Disclosed are compounds of the formula wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agents, pharmaceutical formulations, and methods for the preparation of the compounds.